Justin Meiklem

Vancouver, British Columbia and Rehovot, Israel – February 12, 2025 – BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0), a company pioneering its patented Botanical Synthesis technology platform, today announced that management has been invited to present at the WeBull Consumer Stocks Virtual Webinar taking place on February 18, 2025. […]

Vancouver, British Columbia and Rehovot, Israel – February 10, 2025– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced that that it has applied and received approval for a voluntary delisting of its common shares from the Canadian Securities Exchange (“CSE”). The

Veteran Technology Leader Brings 25+ Years of Financial and Capital Markets Experience to the Board Vancouver, British Columbia and Rehovot, Israel – January 22, 2025– BioHarvest Sciences Inc.,  (Nasdaq: BHST) (CSE: BHSC)  (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today announced that Mr. Sharon Malka has agreed to serve

Vancouver, British Columbia and Rehovot, Israel – January 8, 2025– BioHarvest Sciences Inc., (Nasdaq: BHST) (CSE: BHSC) (FSE: 8MV0) (“BioHarvest” or “the Company”), a company pioneering its patented Botanical Synthesis technology process, today issued a letter to shareholder partners from Chief Executive Officer, Ilan Sobel. Dear Fellow Shareholders, 2024 can be summarized as a year

   New collaboration to pioneer next generation of plant-based ingredients for healthier food and beverages        December 11, 2024 – London, UK and Vancouver, Canada – Tate & Lyle PLC(‘Tate & Lyle’), a world leader in ingredient solutions for healthier and tastier food and beverages, and BioHarvest Sciences (NASDAQ:BHST) (CSE:BHSC) (‘BioHarvest’), leaders in Botanical Synthesis, announce

Third Quarter 2024 Revenue Increased 101% Year-over-Year to Over $6.5 Million, Exceeding Management Guidance Vancouver, British Columbia and Rehovot, Israel – November 25, 2024 – BioHarvest Sciences Inc. (NASDAQ: BHST) (CSE: BHSC) (FSE: 8MV0) (“BioHarvest” or the “Company”), a company pioneering its patented Botanical Synthesis technology platform, today reported its financial and operational results for